Abhishek Mittal

Abhishek Mittal

Active Director Director DIN 09560825
DIN 09560825 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Abhishek Mittal

Data last updated:

Abhishek Mittal is a Director at Mikayla Life Sciences Private Limited (since 2022). The company operates in Pharma. Mikayla Life Sciences Private Limited reported revenue of ₹82.9 Lakh (FY 2025).

DIN 09560825
Primary Designation Director
Industry Pharma
First Appointment 07 Apr 2022
Oldest Company Age 4 yrs
Largest company Mikayla Life Sciences Private Limited · ₹82.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20222022₹82.9 Lakh (FY 2025)Active

Board colleagues of Abhishek Mittal

Directorship timeline

Open interactive timeline →
Mikayla Life Sciences Private Limited
Premium access

Shareholding and investment profile for Abhishek Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Mittal

Abhishek Mittal currently holds 1 directorship: Mikayla Life Sciences Private Limited (Director, since 07 Apr 2022, revenue ₹82.9 Lakh (FY 2025)).

Abhishek Mittal was first appointed on 07 Apr 2022 as Director at Mikayla Life Sciences Private Limited.

The current boards of Abhishek Mittal's companies include Divanshu Ahuja (Mikayla Life Sciences Private Limited), Sandeep Mittal (Mikayla Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available